API 0.00% $1.53 australian pharmaceutical industries limited

Ann: Letter to Shareholders - COVID-19 and Trading Update, page-4

  1. 2,432 Posts.
    lightbulb Created with Sketch. 193
    API is undervalued at current prices.... NPAT should exceed previous years with demand high, once we see april 15 report I feel it will re-rate.... good defensive stock to have in current climate..
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.